Azithromycin and Clarithromycin: Overview and Comparison with Erythromycin
Authors:
- Marc S. WhitmanMWMarc S. Whitman
- Allan R. TunkelATAllan R. Tunkel
- 1 June 1992
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 13 (6) , 357-368
Abstract
No abstract availableThis publication has 76 references indexed in Scilit:
- Clarithromycin, a unique macrolideDiagnostic Microbiology and Infectious Disease, 1992
- Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination againstLegionella speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Comparative antimicrobial activity of the new macrolides againstBorrelia burgdorferiEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- The development of macrolides and related compoundsJournal of Antimicrobial Chemotherapy, 1989
- Comparative in vitro activity of the new oral macrolide azithromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Comparative antimicrobial activity of the new macrolide flurithromycin against respiratory pathogensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Comparative in vitro activity of A-56268 against respiratory tract pathogensEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Comparative in vitro activity of the new macroiide A-56268 against MycobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987